These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
354 related articles for article (PubMed ID: 26310380)
21. The C-reactive protein/albumin ratio, a validated prognostic score, predicts outcome of surgical renal cell carcinoma patients. Guo S; He X; Chen Q; Yang G; Yao K; Dong P; Ye Y; Chen D; Zhang Z; Qin Z; Liu Z; Xue Y; Zhang M; Liu R; Zhou F; Han H BMC Cancer; 2017 Mar; 17(1):171. PubMed ID: 28264659 [TBL] [Abstract][Full Text] [Related]
22. C-reactive protein/albumin ratio is a poor prognostic factor of esophagogastric junction and upper gastric cancer. Kudou K; Saeki H; Nakashima Y; Kamori T; Kawazoe T; Haruta Y; Fujimoto Y; Matsuoka H; Sasaki S; Jogo T; Hirose K; Hu Q; Tsuda Y; Kimura K; Ando K; Oki E; Ikeda T; Maehara Y J Gastroenterol Hepatol; 2019 Feb; 34(2):355-363. PubMed ID: 30119141 [TBL] [Abstract][Full Text] [Related]
23. Prognostic value of the C-reactive protein to albumin ratio: a novel inflammation-based prognostic indicator in osteosarcoma. Li YJ; Yao K; Lu MX; Zhang WB; Xiao C; Tu CQ Onco Targets Ther; 2017; 10():5255-5261. PubMed ID: 29138578 [TBL] [Abstract][Full Text] [Related]
24. Preoperative neutrophil-to-lymphocyte ratio predicts the surgical outcome of Xp11.2 translocation/TFE3 renal cell carcinoma patients. Agizamhan S; Qu F; Liu N; Sun J; Xu W; Zhang L; Guo H; Gan W BMC Urol; 2018 Jun; 18(1):60. PubMed ID: 29890986 [TBL] [Abstract][Full Text] [Related]
25. C-Reactive Protein-based Prognostic Measures Are Superior at Predicting Survival Compared with Peripheral Blood Cell Count-based Ones in Patients After Curative Resection for Pancreatic Cancer. Fujiwara Y; Haruki K; Shiba H; Hamura R; Horiuchi T; Shirai Y; Furukawa K; Gocho T; Yanaga K Anticancer Res; 2018 Nov; 38(11):6491-6499. PubMed ID: 30396977 [TBL] [Abstract][Full Text] [Related]
26. Clinical implications of six inflammatory biomarkers as prognostic indicators in Ewing sarcoma. Li YJ; Yang X; Zhang WB; Yi C; Wang F; Li P Cancer Manag Res; 2017; 9():443-451. PubMed ID: 29033609 [TBL] [Abstract][Full Text] [Related]
27. Comparison of the prognostic value of tumour and patient related factors in patients undergoing potentially curative resection of gastric cancer. Dutta S; Crumley AB; Fullarton GM; Horgan PG; McMillan DC Am J Surg; 2012 Sep; 204(3):294-9. PubMed ID: 22444831 [TBL] [Abstract][Full Text] [Related]
28. The predictive value of integrated inflammation scores in the survival of patients with resected hepatocellular carcinoma: A Retrospective Cohort Study. Pang S; Zhou Z; Yu X; Wei S; Chen Q; Nie S; Liang X; Liu L Int J Surg; 2017 Jun; 42():170-177. PubMed ID: 28414120 [TBL] [Abstract][Full Text] [Related]
29. Preoperative high c-reactive protein/albumin ratio is a poor prognostic factor of oral squamous cell carcinoma. Wang Q; Song X; Zhao Y; He Q; Shi M; Xu P; Ni S; Chen Y; Lin J; Zhang L Future Oncol; 2019 Jul; 15(19):2277-2286. PubMed ID: 31237166 [No Abstract] [Full Text] [Related]
30. Systemic prognostic score and nomogram based on inflammatory, nutritional and tumor markers predict cancer-specific survival in stage II-III gastric cancer patients with adjuvant chemotherapy. Liu X; Wu Z; Lin E; Li W; Chen Y; Sun X; Zhou Z Clin Nutr; 2019 Aug; 38(4):1853-1860. PubMed ID: 30075998 [TBL] [Abstract][Full Text] [Related]
31. Clinical Usefulness of Perioperative C-reactive Protein/Albumin Ratio in Patients With Intrahepatic Cholangiocarcinoma: A Retrospective Single Institutional Study. Nakao Y; Yamashita YI; Arima K; Miyata T; Itoyama R; Yusa T; Umezaki N; Yamao T; Nakagawa S; Okabe H; Imai K; Chikamoto A; Baba H Anticancer Res; 2019 May; 39(5):2641-2646. PubMed ID: 31092463 [TBL] [Abstract][Full Text] [Related]
32. Prognostic nutritional index is superior as a predictor of prognosis among various inflammation-based prognostic scores in patients with hepatocellular carcinoma after curative resection. Imai D; Maeda T; Shimokawa M; Wang H; Yoshiya S; Takeishi K; Itoh S; Harada N; Ikegami T; Yoshizumi T; Mori M Hepatol Res; 2020 Jan; 50(1):101-109. PubMed ID: 31692173 [TBL] [Abstract][Full Text] [Related]
33. [Preoperative C-reactive protein/albumin ratio predicts the prognosis of patients with resectable pancreatic cancer]. Luo BY; Yang Y; Duan YF; Cai HH; An Y; Sun DL Zhonghua Wai Ke Za Zhi; 2018 Sep; 56(9):712-717. PubMed ID: 30157579 [No Abstract] [Full Text] [Related]
34. C-Reactive Protein/Albumin Ratio Is an Independent Prognostic Predictor of Survival in Advanced Cancer Patients Receiving Palliative Care. Zhang J; Zhang C; Li Q; Zhang J; Gu X; Zhao W; Chen M; Liu M; Zhang Z; Liao X; Cheng W J Palliat Med; 2019 Dec; 22(12):1536-1545. PubMed ID: 31188054 [No Abstract] [Full Text] [Related]
35. The C-reactive Protein to Albumin Ratio Predicts Long-Term Outcomes in Patients with Pancreatic Cancer After Pancreatic Resection. Haruki K; Shiba H; Shirai Y; Horiuchi T; Iwase R; Fujiwara Y; Furukawa K; Misawa T; Yanaga K World J Surg; 2016 Sep; 40(9):2254-60. PubMed ID: 26956901 [TBL] [Abstract][Full Text] [Related]
36. Preoperative C-reactive protein to albumin ratio is a predictor of survival after pancreatic resection for pancreatic ductal adenocarcinoma. Ikuta S; Aihara T; Yamanaka N Asia Pac J Clin Oncol; 2019 Oct; 15(5):e109-e114. PubMed ID: 30632282 [TBL] [Abstract][Full Text] [Related]
37. Prognostic value of the C-reactive protein/Albumin Ratio (CAR) in patients with operable soft tissue sarcoma. Liang Y; Xiao W; Guan YX; Wang W; Chen HY; Fang C; Zhang X; Zhou ZW Oncotarget; 2017 Nov; 8(58):98135-98147. PubMed ID: 29228679 [TBL] [Abstract][Full Text] [Related]
38. Postoperative ratio of C-reactive protein to albumin is an independent prognostic factor for gastric cancer. Li C; Yang X; Li H; Fu Y; Wang W; Jin X; Bian L; Peng L Eur J Med Res; 2023 Sep; 28(1):360. PubMed ID: 37735699 [TBL] [Abstract][Full Text] [Related]
39. The C-reactive Protein/Albumin Ratio Is an independent Prognostic Factor for Overall Survival in Patients with Nasopharyngeal Carcinoma Receiving Intensity-Modulated Radiotherapy. Tao CJ; Chen YY; Jiang F; Feng XL; Jin QF; Jin T; Piao YF; Chen XZ J Cancer; 2016; 7(14):2005-2011. PubMed ID: 27877215 [TBL] [Abstract][Full Text] [Related]
40. Prognostic value of inflammation-based markers in patients with pancreatic cancer administered gemcitabine and erlotinib. Lee JM; Lee HS; Hyun JJ; Choi HS; Kim ES; Keum B; Seo YS; Jeen YT; Chun HJ; Um SH; Kim CD World J Gastrointest Oncol; 2016 Jul; 8(7):555-62. PubMed ID: 27559435 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]